Profil bibliographique

David A. Liebner

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

115Publications signalées

3414Citations signalées

3Affiliations récentes

Institutions déclarées

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Wexner Medical Center The Ohio State University

Domaines associés

Sarcoma Diagnosis and TreatmentCAR-T cell therapy researchCancer Immunotherapy and BiomarkersVascular Tumors and AngiosarcomasImmunotherapy and Immune Responses

Publications récentes

Accès ouvert 2026 erratumOpenAlex

Correction: Tinoco et al. Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls. Cancers 2026, 18, 641

Gabriel Tinoco, Marium Husain, David A. Liebner, James L. Chen et autres

0 citationsCancers

2026 articleOpenAlex

Outcomes of Talimogene Laherparepvec in Soft Tissue Sarcoma

Taylor Williams, Sabrina Catalano, David A. Liebner, Valerie P. Grignol

0 citationsJournal of Surgical Oncology

Accès ouvert 2026 articleOpenAlex

Line of therapy and proton pump inhibitor use as prognostic factors in advanced soft tissue sarcoma treated with immunotherapy.

Marium Husain, Kyle Hansotia, Pradyoth Sirineni, David A. Liebner et autres

0 citationsJournal of Clinical Oncology

2026 articleOpenAlex

Siltuximab for the prevention of severe immune-related adverse events during immune checkpoint inhibitor rechallenge in advanced cancer: First interim analysis of the CIRES trial.

Mingjia Li, Amir Mortazavi, Floor Jenniskens Backes, Danielle Elise Zimmerman et autres

0 citationsJournal of Clinical Oncology

2026 articleOpenAlex

Longitudinal assessment of circulating tumor DNA as a disease monitoring biomarker in soft tissue sarcoma.

Ankur Sheel, Erin A. Fetzer, Marium Husain, Gabriel Tinoco et autres

0 citationsJournal of Clinical Oncology

2026 articleOpenAlex

Clinical feasibility of 68Ga-DOTATATE PET/CT to identify SSTR-positive soft tissue sarcoma for PRRT selection.

Gabriel Tinoco, David J. Konieczkowski, David A. Liebner, Marium Husain et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Beyond KIT and PDGFRA: Molecular landscape and outcomes of wild-type GIST.

Maximilian Brockwell, Romil Patel, Mary Wandel, Marium Husain et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.

Mark Agulnik, Jason K. Sicklick, S. Patel, Mrinal M. Gounder et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Use of subtype-specific patterns of clinically relevant antibody–drug conjugate targets in sarcoma to guide precision oncology strategies.

Sohil Reddy, Ankur Sheel, Erin A. Fetzer, Marium Husain et autres

0 citationsJournal of Clinical Oncology

2026 conference-abstractOpenAlex

Patient-reported global health to predict negative health outcomes in patients with advanced sarcoma.

Marium Husain, Hisham Alsharif, Yue Yu, Saurabh Chitnis et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Incidence and timing of recurrence after adjuvant Palbociclib in completely resected retroperitoneal liposarcoma

Samantha M. Ruff, Madelaine Norris, Gabriel Tinoco, David A. Liebner et autres

1 citationSurgical Oncology Insight

Accès ouvert 2026 articleOpenAlex

Clear Cell and Histiocytic/Dendritic Cell Sarcomas: Clinical Outcomes, Molecular Features, and Diagnostic Pitfalls

Gabriel Tinoco, Marium Husain, David A. Liebner, James L. Chen et autres

1 citationCancers

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.